This Is How They Do It: The Maryland Case Study in Congressional Insider Trading

By Michael Phillips | MDBayNews

For years, Americans have heard whispers about members of Congress quietly enriching themselves through stock trades timed curiously around committee actions, legislative hearings, and federal regulatory moves. But every so often, a case emerges that strips away the deniability and shows the pattern in its purest form.

A recent series of trades involving Rep. Delaney (D-MD) and the biotech firm IDEXX Laboratories (IDXX) has reignited the question: Are our elected officials serving the public—or their portfolios?

A Timeline That Raises Every Red Flag

The sequence is almost too on-the-nose:

1. The Initial Buy

Rep. Delaney purchases shares in IDXX, a livestock biotechnology company.

2. The Same-Day Spike

That very day, the stock jumps 10%.

Coincidence? Maybe.

But the story doesn’t end there.

3. The Committee Connection

Shortly after Delaney’s investment, the company is referred to the Agriculture Committee (AG)—a committee on which Delaney sits.

Lawmakers routinely receive briefings, economic forecasts, regulatory insights, and early intel about industry shifts long before the public does. Whether or not that information was used here, the optics are terrible—and the pattern is unmistakable.

4. The Political Pile-In

Within three weeks of the committee referral, more members of Congress buy into IDXX.
The stock continues its climb—rising 84% overall.

When multiple lawmakers buy the same stock directly after insider-access events, the public is not wrong to suspect something is broken.

The Pelosi Parallel

This isn’t unique to Maryland. The most infamous example has been the now-legendary “Pelosi Tracker”—a private investor who publicly admits he simply mimics Nancy Pelosi’s stock trades.

He went on Tucker Carlson and explained exactly how it works:

“I just follow what Pelosi buys. She always wins.”

He has reportedly made millions.

Think about that—a retail investor can outperform the S&P 500 just by copying the spouse of a Speaker of the House. That isn’t normal. That isn’t ethical. And it certainly isn’t what representative government was designed for.

Congress Came to Serve the Nation—Not Themselves

Members of Congress now enjoy:

• insider access that no regular investor receives
• the power to influence markets through legislation
• the ability to trade privately on information that would land any Wall Street executive in prison

And they use that power aggressively.

Every election cycle, politicians promise reform. Every session, bipartisan bills to ban congressional stock trading are introduced. And every year, those bills die quietly in committee—killed by the very people whose net worths miraculously soar during their time in public office.

This Is What Insider Trading Looks Like

Imagine if a Fortune 500 executive:

• had advance knowledge of an FDA decision
• sat on a committee regulating the industry
• bought a stock before that information became public
• watched it explode in value
• and then defended it as “just a normal investment”

They would be indicted before the bell rang at Nasdaq.

But in Congress?

It’s business as usual.

Maryland Deserves Better

Marylanders deserve representatives who serve us, not their brokerage accounts. This recent IDXX pattern is yet another reminder of why the public has lost faith in institutions—because Congress plays by rules that would put any ordinary citizen in handcuffs.

It’s time for a simple reform with overwhelming bipartisan support among voters:

Members of Congress should not be allowed to buy or trade individual stocks. Period.

Blind trusts—or no trades at all—are the only solution.

Until then, insider trading by elected officials won’t be the exception.
It will be the business model.